Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dexamphetamine
(S)-1-phenyl-2-aminopropane
(+)-α-methylphenylethylamine
Dexamfetaminum
Dexamfetamina
(S)-(+)-β-phenylisopropylamine
(S)-α-methylbenzeneethanamine
(+)-(S)-amphetamine
Dexamfetamine
Dextroamphetamine adipate
(+)-amphetamine
Dextroamphetamine
Dextroamphetamine sulfate
Dextroamphetamine saccharate
Dexanfetamina
Desamfetamina
(αS)-α-methylbenzeneethanamine
(S)-1-phenyl-2-propylamine
(S)-amphetamine
d-amphetamine
(+)-α-methylphenethylamine
(S)-(+)-amphetamine
Brand Names
Dexedrine
ProCentra
DEXEDRINE Spansule
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
PMS-dextroamphetamine
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
